147,382 members

Skip to content. | Skip to navigation

News

Use of NICE appraised medicines in the NHS in England - 2009, experimental statistics

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Use of NICE appraised medicines in the NHS in England - 2009, experimental statistics

The National Institute for Health and Clinical Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS

As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England.

The NHS Information Centre was asked to produce a bulletin looking at variation in the use of these medicines in relation to the number of eligible patients as estimated by NICE. Data on the number of patients being treated is not available and so predicted use (using the average dose and average length of treatment) was compared with observed use. Data on observed use in 2009 was taken from the primary care prescribing data from NHS Prescribing Services and secondary care data provided by IMSHealth. More ….